Newfound Research LLC Bio Techne Corp Transaction History

Newfound Research LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$322.67 - $449.65 $33,880 - $47,213	-105 Reduced 37.1%	178 $62,000
Q1 2022 May 04, 2022	BUY	$353.85 - $487.79 $100,139 - $138,044	283 New	283 $123,000
Q3 2021 Oct 14, 2021	SELL	$444.87 - $538.88 $44,931 - $54,426	-101 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$387.35 - $450.26 $39,122 - $45,476	101 New	101 $45,000
Q1 2021 Apr 28, 2021	SELL	$314.62 - $411.0 $40,585 - $53,019	-129 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$246.9 - $321.87 $31,850 - $41,521	129 New	129 $41,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.